Search research articles
Contact Us
Filters
Showing results (41-50 of 50) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 50 results.
The Journal of Infectious Diseases
|
August 8, 2013
Immunogenicity, safety, and immune persistence of a novel inactivated human enterovirus 71 vaccine: a phase II, Randomized, double-blind, placebo-controlled Trial
Yan-Ping Li, Zheng-Lun Liang, Jie-Lai Xia, et al.
Human Vaccines & Immunotherapeutics
|
May 30, 2023
Safety and immunogenicity of a bivalent HPV16/18 vaccine in Chinese females
Li-Wei Shi, Juan Li, Bang-Wei Yu, et al.
Human Vaccines & Immunotherapeutics
|
November 27, 2019
Lot-to-lot consistency study of an <i>Escherichia coli</i>-produced bivalent human papillomavirus vaccine in adult women: a randomized trial
Ying-Ying Su, Bi-Zhen Lin, Hui Zhao, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
November 2, 2019
Burden of viral gastroenteritis in children living in rural China: Population-based surveillance
Jin-Xia Wang, Hong-Lu Zhou, Zhao-Jun Mo, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi
|
November 19, 2011
[Immunogenicity and safety of DTaP-IPV//PRP-T combined vaccine in infants in China]
Yan-ping Li, Feng-xiang Li, Qi-ming Hou, et al.
Vaccine
|
October 18, 2011
Antibody persistence at 18-20 months of age and safety and immunogenicity of a booster dose of a combined DTaP-IPV//PRP∼T vaccine compared to separate vaccines (DTaP, PRP∼T and IPV) following primary vaccination of healthy infants in the People's Republic of China
Rong Cheng Li, Feng Xiang Li, Yan Ping Li, et al.
Vaccine
|
January 12, 2011
Immunogenicity and safety of a pentavalent acellular pertussis combined vaccine including diphtheria, tetanus, inactivated poliovirus and conjugated Haemophilus Influenzae type b polysaccharide for primary vaccination at 2, 3, 4 or 3, 4, 5 months of age in infants in China
Rong Cheng Li, Feng Xiang Li, Yan Ping Li, et al.
Vaccine
|
November 4, 2024
Comparison of the safety and persistence of immunogenicity of bivalent HPV16/18 vaccine in healthy 9-14-year-old and 18-26-year-old Chinese females: A randomized, double-blind, non-inferiority clinical trial
Juan Li, Li-Wei Shi, Ke Li, et al.
Lancet (London, England)
|
December 19, 2009
Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial
Xiao-Feng Liang, Hua-Qing Wang, Jun-Zhi Wang, et al.
Journal of the National Cancer Institute
|
May 16, 2019
Efficacy, Safety, and Immunogenicity of an Escherichia coli-Produced Bivalent Human Papillomavirus Vaccine: An Interim Analysis of a Randomized Clinical Trial
You-Lin Qiao, Ting Wu, Rong-Cheng Li, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 50) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 50 results.
The Journal of Infectious Diseases
|
August 8, 2013
Immunogenicity, safety, and immune persistence of a novel inactivated human enterovirus 71 vaccine: a phase II, Randomized, double-blind, placebo-controlled Trial
Yan-Ping Li, Zheng-Lun Liang, Jie-Lai Xia, et al.
Human Vaccines & Immunotherapeutics
|
May 30, 2023
Safety and immunogenicity of a bivalent HPV16/18 vaccine in Chinese females
Li-Wei Shi, Juan Li, Bang-Wei Yu, et al.
Human Vaccines & Immunotherapeutics
|
November 27, 2019
Lot-to-lot consistency study of an <i>Escherichia coli</i>-produced bivalent human papillomavirus vaccine in adult women: a randomized trial
Ying-Ying Su, Bi-Zhen Lin, Hui Zhao, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
November 2, 2019
Burden of viral gastroenteritis in children living in rural China: Population-based surveillance
Jin-Xia Wang, Hong-Lu Zhou, Zhao-Jun Mo, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi
|
November 19, 2011
[Immunogenicity and safety of DTaP-IPV//PRP-T combined vaccine in infants in China]
Yan-ping Li, Feng-xiang Li, Qi-ming Hou, et al.
Vaccine
|
October 18, 2011
Antibody persistence at 18-20 months of age and safety and immunogenicity of a booster dose of a combined DTaP-IPV//PRP∼T vaccine compared to separate vaccines (DTaP, PRP∼T and IPV) following primary vaccination of healthy infants in the People's Republic of China
Rong Cheng Li, Feng Xiang Li, Yan Ping Li, et al.
Vaccine
|
January 12, 2011
Immunogenicity and safety of a pentavalent acellular pertussis combined vaccine including diphtheria, tetanus, inactivated poliovirus and conjugated Haemophilus Influenzae type b polysaccharide for primary vaccination at 2, 3, 4 or 3, 4, 5 months of age in infants in China
Rong Cheng Li, Feng Xiang Li, Yan Ping Li, et al.
Vaccine
|
November 4, 2024
Comparison of the safety and persistence of immunogenicity of bivalent HPV16/18 vaccine in healthy 9-14-year-old and 18-26-year-old Chinese females: A randomized, double-blind, non-inferiority clinical trial
Juan Li, Li-Wei Shi, Ke Li, et al.
Lancet (London, England)
|
December 19, 2009
Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial
Xiao-Feng Liang, Hua-Qing Wang, Jun-Zhi Wang, et al.
Journal of the National Cancer Institute
|
May 16, 2019
Efficacy, Safety, and Immunogenicity of an Escherichia coli-Produced Bivalent Human Papillomavirus Vaccine: An Interim Analysis of a Randomized Clinical Trial
You-Lin Qiao, Ting Wu, Rong-Cheng Li, et al.
Page
of 5